Seth C. Hopkins - Concepedia

Author

Seth C. Hopkins

Vion Pharmaceuticals (United States)ORCID

Also Known As

S Hopkins, S. C. Hopkins, S. Hopkins, S.C. Hopkins, Seth C Hopkins, Seth C. Hopkins, Seth Cabot Hopkins, Seth Hopkins

112

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Vion Pharmaceuticals (United States)Sunovion (United States)King's College London University of Pennsylvania Yale University

About

Seth C. Hopkins is an author at Vion Pharmaceuticals (United States) specializing in medicine, social sciences, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	244
2	Social Sciences	7	7	182
3	Engineering	2	2	298
4	Health Sciences	2	2	298
5	Natural Sciences	1	1	32

Seth C. Hopkins

Publications

Citations

H-Index

Page 1

	Year	Citations
A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia Kenneth S. Koblan, Justine Kent, Seth C. Hopkins, New England Journal of Medicine	2020	278
Dynamic measurement of myosin light-chain-domain tilt and twist in muscle contraction John E. T. Corrie, Birgit Brandmeier, Roisean E. Ferguson, Nature MechanobiologyMuscle PhysiologyMuscle FunctionEngineeringDynamic Measurement	1999	219
SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action Nina Dedic, Philip Jones, Seth C. Hopkins, Journal of Pharmacology and Experimental Therapeutics	2019	168
Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine Michelle Kokkinou, Elaine E. Irvine, David R. Bonsall, Molecular Psychiatry	2020	102
Fluorescence Polarization Transients from Rhodamine Isomers on the Myosin Regulatory Light Chain in Skeletal Muscle Fibers Seth C. Hopkins, Cibele Sabido-David, John E. T. Corrie, Biophysical Journal	1998	90
Inhibitors of Kinesin Activity from Structure-Based Computer Screening Seth C. Hopkins, Ronald D. Vale, Irwin D. Kuntz Biochemistry	2000	80
Orientation Changes of the Myosin Light Chain Domain During Filament Sliding in Active and Rigor Muscle Seth C. Hopkins, Cibele Sabido-David, Uulke A. van der Heide, Journal of Molecular Biology MechanobiologyFilament SlidingMuscle PhysiologyMuscle FunctionKinesiology	2002	79
Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study Christoph U. Correll, Kenneth S. Koblan, Seth C. Hopkins, Schizophrenia	2021	79
Model-Independent Analysis of the Orientation of Fluorescent Probes with Restricted Mobility in Muscle Fibers Robert E. Dale, Seth C. Hopkins, U.A. an der Heide, Biophysical Journal	1999	71
Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia Michele L. R. Heffernan, Lee W. Herman, Scott P. Brown, ACS Medicinal Chemistry Letters Taar1 Agonism DataPsychopharmacologyPharmacotherapySocial SciencesPsychoactive Drug	2021	66

Page 1